Heiner Wolters

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke et al. · Transplantation · 2015 · 409 citations · Full text

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT

Lutz Fischer, J. Klempnauer, Susanne Beckebaum et al. · American Journal of Transplantation · 2012 · 188 citations · Full text

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial

Oliver Witzke, Ingeborg A. Hauser, Michael Bartels et al. · Transplantation · 2011 · 173 citations

Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial

Oliver Thomusch, Michael S. Wiesener, Mirian Opgenoorth et al. · The Lancet · 2016 · 160 citations

Urology, Transplantation, Kidney Transplant +8

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Andreas A. Schnitzbauer, Carl Zuelke, Christian Graeb et al. · BMC Cancer · 2010 · 159 citations · Full text